Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.3 EUR
430.01 M EUR
3.74 B EUR
50.58 M
About Charles River Laboratories International, Inc.
Sector
CEO
James C. Foster
Website
Headquarters
Wilmington
Founded
1947
FIGI
BBG000CSQ8N3
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
CRL5145814
Charles River Laboratories International, Inc. 3.75% 15-MAR-2029Yield to maturity
5.93%
Maturity date
Mar 15, 2029
CRL5145816
Charles River Laboratories International, Inc. 4.0% 15-MAR-2031Yield to maturity
5.87%
Maturity date
Mar 15, 2031
CRL4900987
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
5.71%
Maturity date
May 1, 2028
CRL4900988
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
—
Maturity date
May 1, 2028
Explore more bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHARL.RIV.LAB INTL DL-,01 stocks are traded under the ticker RV6.
We've gathered analysts' opinions on CHARL.RIV.LAB INTL DL-,01 future price: according to them, RV6 price has a max estimate of 233.25 EUR and a min estimate of 140.88 EUR. Watch RV6 chart and read a more detailed CHARL.RIV.LAB INTL DL-,01 stock forecast: see what analysts think of CHARL.RIV.LAB INTL DL-,01 and suggest that you do with its stocks.
Yes, you can track CHARL.RIV.LAB INTL DL-,01 financials in yearly and quarterly reports right on TradingView.
CHARL.RIV.LAB INTL DL-,01 is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
RV6 earnings for the last quarter are 2.33 EUR per share, whereas the estimation was 2.18 EUR resulting in a 6.91% surprise. The estimated earnings for the next quarter are 2.41 EUR per share. See more details about CHARL.RIV.LAB INTL DL-,01 earnings.
CHARL.RIV.LAB INTL DL-,01 revenue for the last quarter amounts to 906.91 M EUR, despite the estimated figure of 876.58 M EUR. In the next quarter, revenue is expected to reach 934.27 M EUR.
RV6 net income for the last quarter is 61.68 M EUR, while the quarter before that showed 84.01 M EUR of net income which accounts for −26.58% change. Track more CHARL.RIV.LAB INTL DL-,01 financial stats to get the full picture.
No, RV6 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 15, 2024, the company has 21.80 K employees. See our rating of the largest employees — is CHARL.RIV.LAB INTL DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHARL.RIV.LAB INTL DL-,01 EBITDA is 854.49 M EUR, and current EBITDA margin is 23.62%. See more stats in CHARL.RIV.LAB INTL DL-,01 financial statements.
Like other stocks, RV6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHARL.RIV.LAB INTL DL-,01 stock right from TradingView charts — choose your broker and connect to your account.